vimarsana.com

Latest Breaking News On - Arterra bioscience - Page 2 : vimarsana.com

Arterra Bioscience increases turnover by 26 percent in first quarter

Arterra Bioscience Spa on Monday reported that in the first quarter of the year it increased sales by 26 percent to EUR1.1 million from EUR862,870 as of March 31, 2023. Maria Gabriella Colucci,.

Mib caresses 34,000; Amplifon bullish

On Monday, Milan closed on a bullish trend, with the blue chip index hovering just below 34,000 points, a level that was nevertheless surpassed during the session, in line with the performance of.

ITALY GROWTH WINNERS & LOSERS: Askoll EVA rallying; Alfonsino trailing

The following stocks are the best and worst performers on Italy Growth on Wednesday afternoon in Piazza Affari. - WINNERS Askoll EVA ahead 11 percent on Wednesday reported.

Arterra Bioscience with profit down; board confirms dividend

The board of directors of Arterra Bioscience Spa on Friday approved the draft financial statements for the year ended Dec. 31, which closed with a net profit for 2023 of about EUR1.1 million or 22.

Arterra, decree consessione agevolzioni bando Rome Technopole

Arterra Bioscience Spa let it be known Thursday that a decree has been signed granting facilities under the Rome Technopole program call approved by the University of Rome Tor Vergata, for the.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.